FDA.reportPublic FDA data

benzalkonium / idoxuridine

RxCUI
1008664
RxNorm name
benzalkonium / idoxuridine
Term type
MIN
Status
Active
Updated
2026-07-30 22:45:39

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzalkonium1378
idoxuridine5653

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRbenzalkonium / idoxuridineNAMES
RxNorm Namebenzalkonium / idoxuridineNAMES
TTYMINATTRIBUTES
RxCUI1008664CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR02AAAntisepticsATC1-4benzalkonium
ATCD06BBAntiviralsATC1-4idoxuridine
ATCS01ADAntiviralsATC1-4idoxuridine
ATCD09AAMedicated dressings with antiinfectivesATC1-4benzalkonium
ATCJ05ABNucleosides and nucleotides excl. reverse transcriptase inhibitorsATC1-4idoxuridine
ATCD08AJQuaternary ammonium compoundsATC1-4benzalkonium
FDASPLN0000175459Nucleoside AnalogCHEMhas_chemical_structureidoxuridine
FDASPLN0000175466Nucleoside Analog AntiviralEPChas_epcidoxuridine
MEDRTD001548Benzalkonium CompoundsCHEMhas_ingredientbenzalkonium
MEDRTD007065IdoxuridineCHEMhas_ingredientidoxuridine
MEDRTD001424Bacterial InfectionsDISEASEmay_preventbenzalkonium
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzalkonium
MEDRTD004342Drug HypersensitivityDISEASEci_withidoxuridine
MEDRTD007635Keratitis, DendriticDISEASEmay_treatidoxuridine
MEDRTN0000000233Nucleic Acid Synthesis InhibitorsMOAhas_moaidoxuridine
MEDRTN0000009766Nucleic Acid Replication AlterationPEhas_peidoxuridine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESTTYMIN
CODESRxCUI1008664
NAMESRXNAV_STRbenzalkonium / idoxuridine
NAMESRxNorm Namebenzalkonium / idoxuridine